RECOMBINANT MOUSE CYTOCHROMES P-1-450 AND P-3-450 - ENZYMATIC CHARACTERIZATION OF THE HEMOPROTEIN EXPRESSED IN HUMAN-CELLS INFECTED WITH RECOMBINANT VACCINIA VIRUS
K. Nouso et al., RECOMBINANT MOUSE CYTOCHROMES P-1-450 AND P-3-450 - ENZYMATIC CHARACTERIZATION OF THE HEMOPROTEIN EXPRESSED IN HUMAN-CELLS INFECTED WITH RECOMBINANT VACCINIA VIRUS, Acta medica Okayama, 47(6), 1993, pp. 377-382
We expressed mouse cytochrome P-1-450 and P-3-450 using recombinant va
ccinia virus gene expression system in HeLa cells that were devoid of
significant basal levels of P-450. HeLa cells were infected with the r
ecombinant vaccinia virus containing either mouse cytochrome P-1-450 o
r P-3-450 cDNA, and the cell lysates were analyzed for the kinetics of
P-450 enzyme activity and protein expression at the same time. 7-Etho
xycoumarin O-deethylase and ethoxyresorufin O-deethylase activities we
re measured as an expression of the cytochrome P-450 enzyme activities
. Both cell lines began to express these enzyme activities as early as
12h after infection. The activities increased linearly up to the 24h
time point, and were kept for 36h. Western immunoblot analysis showed
that these cytochrome P-450 protiens were detected at 16h and reached
maximum quantity at 24h after infection. These data showed a good corr
elation between cytochrome P-450 enzyme activity and protein concentra
tion throughout the process of P-450 gene expression by vaccinia virus
vector, suggesting a complete formation of cytochrome P-450 holoenzym
e from the early stage of the protein expression.